Sanofi-Aventis bolsters Chinese R&D activities
This article was originally published in Scrip
Executive Summary
Sanofi-Aventishas become the latest multinational to expand its R&D activities in China, opening a new biometrics facility in Beijing and striking a drug discovery agreement with a group of research institutes in Shanghai.